Segment Reporting - Schedule of Significant Segment Expenses (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Segment Reporting [Abstract] | ||||
| Personnel related costs | $ 1,932 | $ 3,980 | $ 4,143 | $ 8,667 |
| Clinical trial expenses | 1,482 | 1,240 | 2,480 | 2,364 |
| Facilities expense | 1,380 | 1,633 | 2,904 | 3,469 |
| Other research and development expenses | 793 | 1,357 | 1,517 | 4,173 |
| Other general and administrative expenses | 1,261 | 1,831 | 2,683 | 3,597 |
| Stock-based compensation expense | 552 | 625 | 1,097 | 1,334 |
| Other segment expenses | 171 | 348 | 374 | 747 |
| Total significant segment expenses | 7,571 | 11,014 | 15,198 | 24,351 |
| Impairment charges | 808 | 0 | 808 | 0 |
| Total operating expense | $ 8,379 | $ 11,014 | $ 16,006 | $ 24,351 |
| X | ||||||||||
- Definition Clinical trial expenses. No definition available.
|
| X | ||||||||||
- Definition Facilities expenses No definition available.
|
| X | ||||||||||
- Definition Segment expenses. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|